Series D Biotechnology Companies

Allay Therapeutics offers analgesic products for post-surgical pain management and recuperation.

GRIN Therapeutics is at the forefront of developing targeted therapies for rare, severe neurodevelopmental disorders.

Pathos is a biotechnology company that leverages AI to accelerate oncology drug development.

Proscia develops digital pathology software designed to help laboratories and life sciences organizations manage and analyze pathology data.

Vivace Therapeutics is a venture-backed start-up dedicated to discovering and developing cancer therapeutics by targeting a novel pathway.

Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.

Clear Labs is a biotechnology firm that integrates a genomics system to simplify diagnostics for the clinical and application sectors.

ALENTIS Therapeutics is a Swiss-French biotech company developing novel therapeutics in advanced liver disease and cancer.

Agomab is a biotechnology company developing therapies that maintains and restores organ function in diseases characterized by fibrosis.

ONL Therapeutics is a biopharmaceutical company dedicated to protecting vision through the protection of photoreceptors.

CSA Medical is a provider of innovative spray cryotherapy medical device solutions.

EGenesis is a gene editing and genome engineering company developing human-compatible engineered organs to treat diseases.

Moximed develops innovative therapies for patients with knee osteoarthritis.

leon-nanodrugs is a nanotechnology-based drug development company.

Truvian Sciences develops an automated benchtop system to provide lab-accurate blood testing results.

CatalYm is a biotechnology company developing innovative immunotherapies for cancer patients.

TMRW Life Sciences provides an integrated platform for automated, software-guided cryospecimen management.

MycoWorks is a biotechnology company that offers non-plastic and non-animal materials to the market.

Formation Bio is a drug development company that strives to provide treatments to patients faster by reimagining clinical trials.

BillionToOne is a precision diagnostics company that focuses on genetic testing for disease detection.

Variantyx is a molecular diagnostics company specializing in advanced genetic testing and diagnostics.

Nectero Medical develops a novel treatment to stabilize growth and prevent rupture of mid-sized abdominal aortic aneurysms.

SeLux Diagnostics is a developer of a next-generation phenotyping platform that provides personalized antimicrobial therapies to patients.

Phagenesis is engaged in the development of a device to treat dysphagia, a condition that disables the safe swallowing of food.

NewLeaf Symbiotics is an agtech company focused on developing sustainable agricultural products using bacteria and related microbes.